thanks big tuna very insightful
so let's call it 25x revenue based on 85 cents target with VMKs 720 million shares on issue be generous 600m cap strip off say 20m cash to get to an EV of 580
and cash flow break even say
looks a little expensive but I don't have the unique almost insider like insight that VMK does...should work i investor relations or maybe they do
I also suspect that when management talk about ARR it is a gross number and not a net number before they pay away their partner network
but I remain open minded
- Forums
- ASX - By Stock
- LVT
- Ann: 1st Half FY19 Results Announcement
Ann: 1st Half FY19 Results Announcement, page-97
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LVT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online